Skip to main content

Advertisement

SpringerLink
Log in

Two-year, prospective, multicenter study of the use of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in the clinical setting in France

  • Letter to the Editor
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Korobelnik JF, Kodjikian L, Delcourt C, Gualino V, Leaback R, Pinchinat S, Velard ME (2016) Two-year, prospective, multicenter study of the use of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in the clinical setting in France. Graefes Arch Clin Exp Ophthalmol. doi:10.1007/s00417-016-3394-y

    PubMed  PubMed Central  Google Scholar 

  2. Freund KB, Korobelnik JF, Deveny R et al (2015) Treat-and extend regimens with anti-VEGF agents in retinal diseases. Retina 35:1489–1506

    Article  CAS  PubMed  Google Scholar 

  3. Chan A, Duker JS, Ko TH, Fujimoto JG, Schuman JS (2006) Normal macular thickness measurements in healthy eyes using stratus optical coherence tomography. Arch Ophthalmol 124:193–198

    Article  PubMed  PubMed Central  Google Scholar 

  4. Gover S, Murthy RK, Brar VS, Chalam KV (2009) Normative data formacular thickness by high-definition spectral-domain optical coherence tomography (spectralis). Am J Ophthalmol 148:266–271

    Article  Google Scholar 

  5. Kuppermann BD, Haller JA, Bandello F (2014) Onset and duration of visual acuity improvement after dexamethasone intravitreal implant in eyes with macular edema due to retinal vein occlusion. Retina 34:1743–1749

    Article  CAS  PubMed  Google Scholar 

  6. Coscas G, Augustin A, Bandello F et al (2014) Retreatment with ozurdex for macular edema secondary to retinal vein occlusion. Eur J Ophthalmol 24:1–9

    Article  PubMed  Google Scholar 

  7. Călugăru D, Călugăru M (2015) Intravitreal bevacizumab in acute central/hemicentral retinal vein occlusions: three-year 2results of a prospective clinical study. J Ocul Pharmacol Ther 31:78–86

    Article  PubMed  Google Scholar 

  8. Călugăru D, Călugăru M (2016) Injection scheme for intravitreal bevacizumab therapy for macular oedema due to central retinal vein occlusion: results of a multicenter study. Acta Ophthalmol 94:80–81

    Google Scholar 

  9. Călugăru D, Călugăru M (2015) Therapies for macular edema associated with central retinal vein occlusions. Ophthalmology 122:65–66

    Article  Google Scholar 

  10. Călugăru D, Călugăru M (2016) Pro-permeability factors after dexamethasone implant in retinal vein occlusion: the ozurdex for retinal vein occlusion (ORVO) study. Am J Ophthalmol 161:215–216

    Article  PubMed  Google Scholar 

Download references

Acknowledgments/disclosure

All authors have completed and submitted the ICMJE form for disclosure of potential conflicts of interest. No financial disclosures. Both authors (D.C and M.C) were involved in design and conduct of the study; collection, management, analysis and interpretation of the data; and preparation, review or approval of the manuscript.

The authors have full control of the primary data and they agree to allow Graefe’s Archive for Clinical and Experimental Ophthalmology to review their data if requested.

Author information

Authors and Affiliations

  1. Department of Ophthalmology, University of Medicine Cluj-Napoca/Romania, Cluj-Napoca, Romania

    Dan Călugăru & Mihai Călugăru

Authors
  1. Dan Călugăru
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mihai Călugăru
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mihai Călugăru.

Ethics declarations

Conflict of interest

All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Călugăru, D., Călugăru, M. Two-year, prospective, multicenter study of the use of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in the clinical setting in France. Graefes Arch Clin Exp Ophthalmol 255, 211–212 (2017). https://doi.org/10.1007/s00417-016-3512-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00417-016-3512-x

Keywords

Search

Navigation